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The Wiskott-Aldrich syndrome is a rare X-
linked human immunodefi ciency with af-
fected patients developing recurrent infections, 
thrombocytopenia, eczema, and, in up to 70% 
of cases, autoimmunity (1). WASP is a multi-
domain-containing protein that regulates the 
actin cytoskeleton in hematopoietic cells. In 
T cells, after TCR activation, Wiskott-Aldrich 
syndrome protein (WASP) relocalizes to lipid 
rafts, regulating localized actin polymerization 
and the formation/function of an immuno-
logical synapse (2–5). In peripheral T cells, 
the absence of WASP leads to aberrant actin 
rearrangement and immunological synapse 
formation with associated decreases in TCR-
induced proliferation and aberrant IL-2 pro-
duction (3–7).
WASP-defi cient (WASP knockout [WKO]) 
mice share many features of the human 
 disease, including global defects in leukocyte 
migration and podosome formation, defects 
in T and B cell signaling, defects in the gener-
ation of eff ective immune responses, and the 
development of autoimmunity (6–10). The 
majority of WKO mice develop an infl am-
matory bowel disease (IBD) limited to the 
colon (6, 11). Adoptive transfer of WKO 
CD4+ T cells is suffi  cient to induce colitis in 
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The Wiskott-Aldrich syndrome, a primary human immunodefi ciency, results from defective 
expression of the hematopoietic-specifi c cytoskeletal regulator Wiskott-Aldrich syndrome 
protein (WASP). Because CD4+CD25+Foxp3+ naturally occurring regulatory T (nTreg) cells 
control autoimmunity, we asked whether colitis in WASP knockout (WKO) mice is associ-
ated with aberrant development/function of nTreg cells. We show that WKO mice have 
decreased numbers of CD4+CD25+Foxp3+ nTreg cells in both the thymus and peripheral 
lymphoid organs. Moreover, we demonstrate that WKO nTreg cells are markedly defective 
in both their ability to ameliorate the colitis induced by the transfer of CD45RBhi T cells 
and in functional suppression assays in vitro. Compared with wild-type (WT) nTreg cells, 
WKO nTreg cells show signifi cantly impaired homing to both mucosal (mesenteric) and 
peripheral sites upon adoptive transfer into WT recipient mice. Suppression defects may be 
independent of antigen receptor–mediated actin rearrangement because both WT and WKO 
nTreg cells remodeled their actin cytoskeleton ineffi ciently upon T cell receptor stimulation. 
Preincubation of WKO nTreg cells with exogenous interleukin (IL)-2, combined with anti-
gen receptor–mediated activation, substantially rescues the suppression defects. WKO 
nTreg cells are also defective in the secretion of the immunomodulatory cytokine IL-10. 
Overall, our data reveal a critical role for WASP in nTreg cell function and implicate nTreg 
cell dysfunction in the autoimmunity associated with WASP defi ciency.
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immunodefi cient hosts (unpublished data). Although WKO 
CD4+ T cells can induce colitis, it is not clear whether coli-
tis in WKO mice is the result of an abnormal autoreactive 
eff ector T cell population, a defect in a regulatory T cell 
population, or a combination of defects in both eff ector and 
regulatory T cell function.
Naturally occurring regulatory T (nTreg) cells are defi ned 
as a subgroup of CD4+CD25+ T cells that express the fork-
head winged helix transcription factor Foxp3 and are able to 
modulate T cell responses (12–14). nTreg cells have been im-
plicated broadly in immune regulation and have been found 
to modulate transplantation tolerance, autoimmunity, tumor 
immunity, and the immune response against pathogens (for 
review see references 15–20). An imbalance between eff ector 
T cells and regulatory T cells has been implicated in many 
murine models of IBD. A role for nTreg cells has perhaps 
been defi ned most clearly in the CD45RB transfer model 
(21). In this model, adoptive transfer of CD4+CD45RBhi 
T cells (eff ector cells) to immunodefi cient mice results in 
 severe colitis. Cotransfer of CD4+CD45RBlo T cells with 
CD4+CD45RBhi T cells prevents disease induction, demon-
strating the suppressive eff ect of the CD4+CD45RBlo  T regu-
latory cell–containing population.
In this report, we show that WKO mice have reduced 
numbers of CD4+CD25+Foxp3+ T cells in lymphoid or-
gans and hypothesize that colitis in WKO mice results from 
defective regulatory T cell function. We demonstrate that 
nTreg cells from WKO mice fail to protect against the 
colitis induced by WT or WKO CD45RBhi T cells. WKO 
CD4+CD25+ cells are also defective in suppressing the pro-
liferation of WT and WKO CD4+CD25− T cells in vitro. 
Exogenous IL-2 administration in the presence of antigen re-
ceptor stimulation substantially rescues the defect in suppres-
sion. WKO nTreg cells are also defective in the secretion of 
IL-10, a cytokine shown previously to be critical for preven-
tion of colitis (22, 23).
Figure 1. WKO mice have reduced CD4+CD25+Foxp3+ regulatory 
T cell numbers. (A) Flow cytometric analysis of CD4 and CD25 expression 
on WT (left) and WKO (right) splenocytes within a CD4+ lymphocyte gate. 
Numbers indicate the percentage of CD25+ cells in the indicated gate. 
Shown are FACS profi les representative of 18 WT and 24 WKO mice on 
the 129SvEv background. (B) Percentage of CD4+CD25+ T cells within the 
CD4+ gate in the spleen (left), mesenteric lymph node (MLN; middle), and 
inside a CD4+CD8− single positive thymocyte gate (right). The horizontal 
gray bars represent the average. Shown are results of one of fi ve inde-
pendent experiments. (C) Average mean fl uorescence intensity of CD25 
of WT (left; n = 5) and WKO (right; n = 9) CD4+CD25+ splenocytes. 
Error bars represent standard deviations. (D) Decreased percentage of 
CD4+Foxp3+ cells in WKO mice. Shown are density plots of CD4 
and Foxp3 expression in WT (left) and WKO (right) CD4+ lymphocytes 
(mesenteric lymph node). Numbers indicate the percentage of Foxp3+ cells 
in the indicated gate. FACS profi les shown are representative of >10 mice 
in each group. (E) Dot plots of CD25 and Foxp3 expression in CD4+ T cells 
from WT (left) and WKO mice (right). Shown are representative profi les 
from the mesenteric lymph node (similar results were obtained in the 
spleen). Numbers represent the percentage of cells in the corresponding 
quadrant. Data shown is representative of analysis of 10 individual mice 
(129SvEv) in each group. (F) Density plots of CD25 and CD103, CTLA-4, or 
GITR expression on CD4+ splenocytes from WT (left) and WKO (right) 
mice. Numbers represent the percentage of cells inside the corresponding 
quadrants. Shown are data representative of 8 WT and 12 WKO mice. 
*, P < 0.05; **, P < 0.01.
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RESULTS
WKO mice have reduced numbers of CD4+CD25+ 
regulatory T cells
We have previously demonstrated that WKO mice develop 
colitis (6) and that WKO CD4+ T cells are suffi  cient to in-
duce disease when transferred to RAG-2–defi cient mice 
(unpublished data). Because nTreg cells are known to control 
autoimmunity in several disease states (17), we hypothesized 
that the colitis in WKO mice may be associated with aberrant 
diff erentiation, development, or function of nTreg cells. We 
fi rst assessed the numbers of regulatory T cells in lymphoid 
organs from WT and WKO mice. The percentage of 
CD4+CD25+ regulatory T cells in the WKO spleen, mesen-
teric lymph nodes, and thymus was signifi cantly reduced 
when compared with the percentage of nTreg cells in WT 
lymphoid organs (Fig. 1, A and B). In addition, WKO CD4+ 
T cells had reduced expression of cell surface CD25 (Fig. 1 C).
WKO nTreg cells have normal expression of Foxp3 
and other regulatory T cell markers
Regulatory T cell diff erentiation and function is dependent 
on Foxp3, a forkhead winged helix transcription factor (13, 
14, 24). Foxp3−CD4+CD25+ T cells fail to suppress prolif-
eration in vitro (13). The numbers of WKO CD4+Foxp3+ 
T cells, like WKO CD4+CD25+ cells, are also decreased in 
peripheral lymphoid organs (Fig. 1 D). The percentage and 
mean fl uorescence intensity of Foxp3+ cells among WKO 
CD4+CD25+ T regulatory cells is similar to WT T regula-
tory cells, suggesting adequate diff erentiation and lineage 
specifi cation of WKO T regulatory cells despite their reduced 
percentage (Fig. 1, D and E). Cytotoxic T lymphocyte–
 associated antigen 4 (CTLA-4), CD103, and glucocorticoid-
induced TNF receptor (GITR), like CD25, are cell surface 
markers that have been also associated with a regulatory 
CD4+ T cell phenotype (25–27). Expression of CTLA-4, 
CD103, and GITR was indistinguishable between WT and 
WKO CD4+ T cells (Fig. 1 F).
WKO regulatory T cells fail to protect against development 
of colitis in vivo
We fi rst sought to determine whether WASP is required for 
nTreg cell suppression in vivo. To this end, we used a modi-
fi cation of the CD45RB transfer model of colitis (Fig. 2 A) 
(21). This model has the advantage of assessing both eff ector 
and regulatory T cell function. SCID mice were injected 
 intraperitoneally with CD45RBhi T cells from either WT or 
WKO mice alone or in combination with WT or WKO 
CD45RBlo T cells (Fig. 2 A). Mice were assessed weekly for 
clinical signs of colitis for 8 wk, followed by histological 
analysis. WT CD45RBhi T cells, when injected alone, induced 
severe colitis (Fig. 2 B). Colitis induction was suppressed 
when WT CD45RBlo T cells were cotransferred with WT 
CD45RBhi T cells (Fig. 2, B and C). In contrast, WKO 
CD45RBlo T cells were unable to suppress colitis induction 
when cotransferred with WT CD45RBhi T cells (Fig. 2, B 
and C). When CD45RBhi T cells from WKO mice were 
Figure 2. WKO nTreg cells fail to suppress colitis induction in the 
CD45RB transfer model. (A) WT or WKO CD4+CD45RBhi T cells were 
injected alone or together with WT or WKO CD4+CD45RBlo T cells into 
SCID mice at day 0. Mice were assessed clinically weekly for a total of 
8–12 wk followed by histological analysis. In a different set of experiments, 
CD4+CD25+ T cells were used instead of CD4+CD45RBlo T cells. (B) Clini-
cal score of colitis 8 wk after transfer of WT or WKO CD4+CD45RBhi T cells 
and WT or WKO CD4+CD45RBlo T cells. Each dot represents an individual 
mouse. Horizontal bars represent average. Shown are combined data of 
four independent experiments. (C) Hematoxylin and eosin–stained 
cross sections of colonic sections taken 8 wk after transfer of WT 
CD4+CD45RBhi T cells and WT (left) or WKO (right) CD4+CD45RBlo T cells 
to SCID recipient mice. (D) Clinical score of colitis 8 wk after transfer of 
WT or WKO CD4+CD45RBhi T cells and WT or WKO CD4+CD25+ nTreg 
cells. Each dot represents an individual mouse. Horizontal bars represent 
average. Shown are the combined data of three independent experiments. 
NS, Nonsignifi cant (P > 0.05). *, P < 0.05; **, P < 0.01.
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 injected alone, mice developed colitis, although associated 
with later onset and decreased severity (Fig. 2 B). Not 
 surprisingly, fewer CD4+ T cells were recovered from the 
periphery of recipient mice receiving WKO CD45RBhi 
T cells (not depicted). Nonetheless, cotransfer of WKO 
CD45RBlo T cells could not prevent the onset of colitis in 
these mice. As expected, neither WT CD45RBlo nor WKO 
CD45RBlo T cells when injected alone induced colitis (Fig. 
2 B). These data demonstrate that WKO CD45RBlo T cells 
were unable to protect against colitis induction by WT 
CD45RBhi T cells.
To determine whether the CD4+CD25+Foxp3+ nTreg 
cells within the CD45RBlo population were responsible for 
the observed suppression defects, we performed analogous 
cotransfer experiments in which CD4+CD25+ T cells were 
transferred in combination with CD45RBhi T cells (Fig. 2 A). 
As expected, the transfer of WT CD45RBhi T cells alone in-
duced colitis, a process that was blocked by the cotransfer 
of WT CD4+CD25+ T cells (Fig. 2 D). Neither WT nor 
WKO CD4+CD25+ T cells induced colitis when transferred 
alone. Importantly, WKO CD4+CD25+ T cells did not sup-
press colitis induction when cotransferred with WT 
CD45RBhi T cells (Fig. 2 D). However, WKO CD4+CD25+ 
T cells suppressed colitis induction by WKO CD45RBhi. 
These fi ndings, although in contrast to the lack of suppres-
sion seen with WKO CD45RBlo on WKO CD45RBhi 
T cells, correlated well with the enrichment of nTreg cells 
within the CD4+CD25+ population (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20061338/DC1) 
and with our in vitro experiments described below.
We further assessed whether WKO CD45RBhi T cells 
could receive a suppressive signal from WT CD4+CD25+ 
T cells. WT CD4+CD25+ T cells eff ectively blocked colitis in-
duction by WKO CD45RBhi T cells, indicating that WASP 
is not required for CD45RBhi T cells to receive a suppressive 
signal from nTreg cells (Fig. 2 D). In all groups examined, the 
histopathological assessment of colitis correlated well with 
the clinical scores (not depicted). Collectively, these data in-
dicate that WKO nTreg cells are less eff ective at suppressing 
colitis induction in the CD45RB transfer model.
Defective homing of WKO nTreg cells to peripheral 
lymphoid organs
We have previously demonstrated in vitro and in vivo that 
WKO mice have global defects in directed leukocyte migra-
tion (28). We hypothesized that the failure of WKO nTreg 
cells to suppress colitis in the CD45RB transfer model may 
result, at least in part, from defects in migration of WKO 
nTreg cells to target organs. Consistent with this hypothesis, 
the numbers of WKO nTreg cells recovered from the spleen, 
mesenteric lymph nodes, and lamina propria was reduced 
compared with WT nTreg cells in mice cotransferred with 
WT CD45RBhi T cells (Fig. 3 A).
To assess directly whether WKO nTreg cells had defects 
in migration to peripheral lymph nodes, we used an in vivo 
migration assay. Equal numbers of WT and WKO nTreg 
cells were labeled with either tetramethylrhodamine isothio-
cyanate (TRITC) (red) or CFSE (green). Both populations 
were mixed at a ratio of 1:1 immediately before intravenous 
injection into a WT recipient mouse. To monitor the hom-
ing characteristics, recipient mice were killed 12–15 h after 
adoptive transfer. Analogous experiments were performed 
with WT and WKO CD4+CD25− T cells. Lymphoid organs 
were harvested, and single cell suspensions were analyzed 
Figure 3. Defective homing of WKO nTreg cells to peripheral 
lymphoid organs. (A) Reduced accumulation of WKO nTreg cells in 
the CD45RB transfer model. SCID mice were cotransferred with WT 
CD4+CD45RBhi and either WT (left) or WKO (right) nTreg cells. 10 wk after 
transfer, spleen, mesenteric lymph node, and colonic lamina propria cells 
were collected and stained for CD4 and Foxp3. Shown are representative 
dot plots of 6 and 10 mice per group. (B) nTreg cells or CD4+CD25− cells 
were isolated from peripheral lymphoid organs of WT and WKO mice, 
labeled with CFSE (WT) or TRITC (WKO), and mixed at a 1:1 ratio before 
intravenous injection to WT mice. Spleen and peripheral and mesenteric 
lymph nodes of recipient mice were harvested after 12–15 h, and the 
percentage of WKO lymphocyte homing relative to WT was determined. 
Shown are averages ± SD of combined data from two experiments 
including eight (CD4+CD25−) and seven (nTreg cells) mice per group. 
Dashed line represents the input percentage.
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 using fl ow cytometry (Fig. 3 B). There was a statistically sig-
nifi cant decrease in the homing of WKO nTreg cells or 
WKO CD4+CD25− T cells to the spleen and peripheral and 
mesenteric lymph node when compared with WT cells.
In light of the relative homing defects, we asked whether 
the defects in suppression by WKO nTreg cells in the 
CD45RB transfer model of colitis might be overcome by in-
creasing the number of nTreg cells at the time of transfer. 
In contrast to the failure of suppression of colitis by WKO 
nTreg cells when transferred at a standard 1:4 ratio with 
WT CD45RBhi cells, colitis was eff ectively suppressed when 
WKO nTreg cells were transferred at a higher 1:1 ratio (clin-
ical score: 3.3, WT CD45RBhi alone; 0.3, WT CD45RBhi 
plus WT nTreg cell [low dose]; 2.3, WT CD45RBhi plus 
WKO nTreg cell [low dose]; 0.0, WT CD45RBhi plus WKO 
nTreg cell [high dose]; 0.2, WKO nTreg cell alone [high 
dose]; n = 3–5 animals/group).
The observation that transfer of increased numbers of 
WKO nTreg cells (relative to WT) eff ectively suppresses the 
colitis induced by the transfer of CD45RBhi cells is consistent 
with the relatively ineffi  cient homing of WKO nTreg cells to 
mucosal surfaces demonstrated in Fig. 3 (A and B).
WKO nTreg cells have defective suppressor function in vitro
We next sought to extend our in vivo fi ndings by using an in 
vitro suppression assay (29). WT CD4+CD25− T cells were 
cocultured with mitomycin-treated WT APCs in the pres-
ence of anti-CD3ε antibodies and WT or WKO nTreg cells. 
Suppression of proliferation by WT or WKO nTreg cells was 
assessed by [3H]thymidine incorporation. As expected, WT 
nTreg cells effi  ciently suppressed proliferation, readily appar-
ent at a CD25+/CD25− cell ratio of 1:16 (Fig. 4 A) (29). In 
contrast, even at a 1:1 CD25+/CD25− cell ratio, WKO 
nTreg cells failed to suppress the proliferation of WT CD25− 
cells (Fig. 4 A). Moreover, consistent with these fi ndings, 
preliminary data suggest that WT but not WKO nTreg cells 
suppress the secretion of IFN-γ by WT CD25− T cells in this 
coculture system (unpublished data).
As in our in vivo studies, WT nTreg cells inhibited the 
proliferation of WKO CD4+CD25− T cells (Fig. 4 B), dem-
onstrating that WKO responder T cells can receive a suppres-
sive signal coming from WT nTreg cells. However, although 
suppressive at maximal ratios, WKO nTreg cells were less ef-
fective than WT nTreg cells at suppressing proliferation of 
WKO CD4+CD25− (consistent with our in vivo data; Fig. 
2 D). Suppression of WKO but not WT naive T cells by WKO 
nTreg cells may be explained by evidence in vitro and in vivo 
supporting reduced activation/proliferation of WKO eff ec-
tor cells. First, as shown previously with total WKO T cells 
(6, 7), WKO CD4+CD25− T cells proliferate poorly upon anti-
gen receptor activation (Fig. 4). Second, as discussed above, 
WKO CD45RBhi T cells induce colitis upon transfer with 
lower severity than WT CD45RBhi T cells and are associated 
with decreased numbers of T cells in recipient mice.
WKO nTreg cells are not associated with TCR-induced 
defects in actin remodeling
Although remodeling of the actin cytoskeleton and formation 
of an immunological synapse appear to be important for TCR 
signaling in peripheral T cells (30–32), a role for actin remod-
eling and immunological synapse formation has not been de-
scribed for regulatory T cells. Because WASP has been 
demonstrated to regulate actin remodeling and immunological 
synapse formation, we hypothesized that defi ciencies in these 
processes might contribute to WKO nTreg cell dysfunction 
(2–5). When compared with WT CD4+CD25− cells, both 
WT and WKO nTreg cells polarized their actin cytoskeleton 
less effi  ciently upon stimulation with anti-CD3/anti-CD28–
coated beads (Fig. 5, A–C, and Table S1, which is available 
at http://www.jem.org/cgi/content/full/jem.20061338/DC1). 
As expected, WKO CD4+CD25− T cells polarized their 
actin cytoskeleton ineffi  ciently when compared with WT 
CD4+CD25− cells (2–5).
We next analyzed T cell spreading on anti-CD3/anti-
CD28–coated coverslips (Fig. 5, D and E, and Table S1). As 
observed for polarization, we observed a decrease in the 
Figure 4. WKO nTreg cells are defective in suppressing T cell pro-
liferation in vitro. CD4+CD25− cells were isolated from the spleens of 
WT (A) and WKO (B) mice and were cocultured with mitomycin-treated 
T cell–depleted splenocytes and 0.5 μg/ml anti-CD3ε for 3 d in the pres-
ence of varying numbers of CD4+CD25+ regulatory T cells (nTreg cells) 
coming from the spleen of WT (black full line, dots) or WKO (gray dashed 
curve, squares) mice. Proliferation was measured by [3H]thymidine uptake 
(y axis). Ratios of CD25+/CD25− T cells are indicated on the x axis. Shown 
is one representative of fi ve (left) and three (right) independent experi-
ments performed in triplicate.
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spreading of WT nTreg cells when compared with WT 
CD4+CD25− cells at both 10 and 30 min after TCR stimu-
lation (Fig. 5 E and Table S1). The percentage of spread 
WKO nTreg cells was similar to WT nTreg cells. Finally, the 
percentage of spread WKO CD4+CD25− cells was reduced 
when compared with WT CD4+CD25− cells (Fig. 5 E and 
Table S1). Collectively, our data suggest that WT and WKO 
nTreg cells remodel their actin cytoskeleton upon TCR 
stimulation less effi  ciently than CD4+CD25− T cells.
Defective suppression by WKO nTreg cells is substantially 
rescued by exogenous IL-2 stimulation
Previous work has demonstrated that, in vitro, the resistance 
of CD4+CD25+ nTreg cells to TCR-induced stimulation 
can be overcome by the addition of exogenous IL-2 (29). We 
have found that, like WT nTreg cells, the inability of WKO 
nTreg cells to proliferate in response to TCR-induced stimu-
lation is overcome by the addition of exogenous IL-2 (Fig. 6 A). 
IL-2 has also been shown to be required for effi  cient genera-
tion of CD4+CD25+Foxp3+ cells in vivo (33–35) as well as 
for their maximal suppressive activity (36, 37). IL-2 secretion 
is also required to control self-reactive T cells, as demon-
strated by pronounced autoimmune pathologies developed 
by IL-2–defi cient mice (38). Because defective IL-2 secretion 
is one of the hallmarks of WASP defi ciency in T cells, we 
reasoned that WKO nTreg cell dysfunction might result from 
impaired IL-2–induced signaling and inadequate nTreg cell 
activation. To address this issue, we precultured WT or 
WKO CD4+CD25+ nTreg cells with 10 μg/ml of plate-
bound anti-CD3ε and 25 μg/ml IL-2 for 3 d and compared 
suppression to freshly isolated WT or WKO nTreg cells (Fig. 
6 B). As expected, IL-2 preactivation enhanced suppression 
by WT nTreg cells (37). IL-2 preactivation of WKO nTreg 
cells enhanced suppression to levels comparable with freshly 
isolated WT nTreg cells. Although WKO nTreg cell sup-
pressive function improved with exogenous IL-2, the sup-
pressive activity of preactivated WKO nTreg cells was lower 
than that of the preactivated WT nTreg cells, suggesting that 
IL-2–independent signaling defects contribute to WKO 
nTreg cell dysfunction. This is reminiscent of our prior data 
demonstrating rescue, at least in part, of antigen receptor–
mediated defects in proliferation of WKO T cells through 
exogenous addition of IL-2 (6).
Defective IL-10 secretion by WKO nTreg cells
IL-10 has been shown to play a major role in the regulation 
of colitis in the CD45RB transfer model (22, 23, 39). We 
therefore analyzed IL-10 secretion by WKO T cells. WT 
and WKO CD4+CD25+ nTreg cells were cultured for 3 d 
with plate-bound anti-CD3 and IL-2 or PMA and ionomycin, 
Figure 5. WT and WKO nTreg cells ineffi ciently remodel their actin 
cytoskeleton upon T cell receptor activation. (A–C) Reduced actin 
polarization of WT and WKO nTreg cells upon incubation with anti-CD3/
anti-CD28–coated beads. Representative examples of cells with nonpolar-
ized (A) and polarized actin (B) are displayed. Left panels represent phase 
images, and right panels show actin staining. Beads are marked with a 
cross. Bars, 5 μm. The percentage of CD4+CD25− or nTreg cells (black, 
WT; white, WKO) with polarized cytoskeleton relative to WT CD4+CD25− 
is shown in C. For each group, at least 300 conjugated cells have been 
examined. Shown are averages of three independent experiments ± SD. 
(D and E) Reduced T cell spreading by WT and WKO nTreg cells. An exam-
ple of actin staining of WT CD4+CD25− splenocytes 10 min after incuba-
tion on anti-CD3/anti-CD28–coated coverslips is shown in D. Examples of 
spread T cells are indicated by arrowheads, and unspread T cells are repre-
sented by arrows. Bar, 5 μm. The percentage of CD4+CD25− or nTreg cells 
(isolated from WT [black] or WKO [white] mice) that were spread relative 
to WT CD4+CD25− is shown in E. For each group, at least 300 cells have been 
examined. Shown are averages of three independent experiments ± SD. 
NS, Nonsignifi cant (P > 0.05). *, P < 0.05; **, P < 0.01.
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and culture supernatants were harvested to assay IL-10 concen-
tration by ELISA. IL-10 secretion was dramatically decreased 
upon stimulation of WKO nTreg cells (Fig. 6 C). In contrast, 
stimulation with PMA and ionomycin, which bypasses prox-
imal TCR signals, rescued this defect (Fig. 6 C). This defect 
in IL-10 secretion was not nTreg cell specifi c because the 
same defect was observed in WKO CD4+CD25− cells.
DISCUSSION
Autoimmunity is one of the hallmarks of the Wiskott- Aldrich 
syndrome, with a majority of patients suff ering from at 
least one autoimmune disorder (hemolytic anemia, neutro-
penia, arthritis, skin vasculitis, glomerulonephritis, or IBD) 
(1). Likewise, 100% of WKO mice develop colitis by 6 mo 
of age (unpublished data) (6, 11). The colitis in WKO mice 
is unique among murine models of IBD in that it is the only 
model that has a human counterpart. We sought to investi-
gate the mechanisms responsible for the immune dysregula-
tion leading to colitis in WKO mice and postulated that 
abnormalities in the homeostasis/function of regulatory 
T cells may play a contributing role.
CD4+CD25+Foxp3+ regulatory T cells are key regula-
tors of autoreactive T cells in vivo (15–19). In mice, 
CD4+CD25+Foxp3+ nTreg cells are generated in the thy-
mus during the fi rst weeks of life and are dependent on the 
expression of Foxp3 (40). We have demonstrated that WASP 
is important for the homeostasis of CD4+CD25+Foxp3+ T 
cells in the thymus as well as in peripheral lymphoid organs. 
Furthermore, WASP is critically required for the ability of 
CD4+CD25+ T cells to mediate suppression in vivo and in 
vitro. The observed defects in suppression in vivo correlate 
well with the demonstrated defects in homing of WKO 
CD4+CD25+ T cells to target organs, fi ndings that are con-
sistent with the known defects in global migration by WKO 
leukocytes (28). Nonetheless, migration defects cannot fully 
explain the suppression defects because these defects are still 
evident in the in vitro coculture system, an assay in which 
migratory capacity is unlikely to play a signifi cant role.
T cell activation by APCs is associated with reorganiza-
tion of the actin cytoskeleton and the concomitant formation 
of an immunological synapse (31, 32). In peripheral T cells, 
WASP plays a critical role in the reorganization of the actin 
cytoskeleton and immunological synapse formation (3–7). 
We postulated that defects in antigen receptor–induced actin 
remodeling and immunological synapse formation might be 
responsible for the regulatory T cell defects in WKO mice. 
However, both WT and WKO CD4+CD25+ nTreg cells 
poorly remodeled their actin cytoskeleton after antigen re-
ceptor stimulation when compared with WT CD4+CD25− 
nTreg cells. Recently, nTreg cells and dendritic cells have 
been demonstrated to interact directly in vivo (41). Although 
our data do not exclude a role for actin remodeling and 
 immunological synapse formation in nTreg cell function, 
they clearly suggest diff erent signaling requirements for the 
induction of antigen receptor–induced cytoskeletal changes 
in nTreg cells.
Although WASP is not required for the development 
of CD4+ T cells (6, 7), the generation/homeostasis of 
CD4+CD25+Foxp3+ T cells may be particularly sensitive to 
WASP defi ciency. Numerous studies have demonstrated a 
critical role for WASP in antigen receptor–induced signaling 
in T cells (6, 7, 42). Studies using TCR-transgenic mice sug-
gest that WT nTreg cells are generated after recognition of 
self-antigens in the thymus, with nTreg cell–selective events 
Figure 6. Exogenous IL-2 rescues WKO nTreg cell dysfunction. 
(A) WKO nTreg cells do not proliferate upon CD3-mediated stimulation and 
respond to exogenous IL-2. [3H]thymidine uptake of CD4+CD25+ nTreg 
cells isolated from the spleens of WT (black bars) or WKO (white bars) 
mice 3 d after stimulation with mitomycin-treated T cell–depleted spleno-
cytes and 0.5 μg/ml anti-CD3ε or 0.5 μg/ml anti-CD3ε plus 10 μg/ml IL-2. 
Shown are averages ± SD of one representative of three independent 
experiments performed in triplicate. (B) IL-2 and antigen receptor–mediated 
preactivation of WKO nTreg cells substantially rescues their proliferation 
defects. [3H]thymidine uptake of CD4+CD25− T cells isolated from the 
spleens of WT mice and cocultured with CD4+CD25+ cells from WT (black 
curves) or WKO (gray curves) mice at different CD25+/CD25− ratios. 
Dashed curves represent suppressive effects of WT or WKO nTreg cells 
after a prior 3-d activation with 10 μg/ml of plate-bound anti-CD3ε and 
25 μg/ml IL-2. Shown are results of one out of three independent experi-
ments performed in triplicate. (C) Decreased IL-10 secretion of stimulated 
WKO nTreg cells. IL-10 concentrations were determined by ELISA in the 
supernatant of nTreg cells or CD4+CD25− splenocytes isolated from WT 
or WKO mice that were unstimulated or stimulated for 3 d with 10 μg/ml 
anti-CD3ε and 25 μg/ml IL-2, or PMA and ionomycin. Shown are aver-
ages of one representative of four independent experiments, each 
 performed in duplicate. Error bars represent standard deviations.
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requiring relatively high affi  nity interactions (43, 44). CD28 
costimulation and IL-2 are also required for effi  cient nTreg 
cell generation in thymocytes, as illustrated by decreased 
nTreg cell numbers in CD28 knockout and IL-2 knockout 
mice (33, 45, 46). However IL-2 appears to have a more 
critical role in nTreg cell maintenance in the periphery (33). 
Although CD28-mediated signals have been shown to partly 
rescue the proliferation defects of WKO T cells (4, 6), and 
potential defects in CD28 costimulation in WKO nTreg cells 
were not assessed in this report, a complementary report sug-
gests that CD28 signaling does not rescue the defects in pro-
liferation by WKO nTreg cells (see Marangoni et al. on 
p. 369 of this issue). Defects in IL-2 production and secretion 
have been observed consistently in WKO T cells (2, 6, 7, 42). 
Exogenous IL-2 can rescue, at least in part, antigen receptor–
induced signaling events in both naive WKO T cells (6, 7) 
and WKO nTreg cells. We have also demonstrated a reduc-
tion in CD25 (i.e., IL-2Rα) surface expression on WKO 
nTreg cells. Collectively, we hypothesize that defective IL-2 
production and antigen receptor activation contribute to the 
observed decrease in numbers and function of naturally oc-
curring nTreg cells in WKO mice (Fig. 7). This defect in 
 antigen receptor activation may result, in part, by an increase 
in the activation threshold of WKO nTreg cells that is over-
come by IL-2 stimulation. This is further supported by recent 
complementary data directly demonstrating that proliferative 
defects of WKO nTreg cells can be diminished with increased 
stimulation through the TCR (Marangoni et al., in this 
 issue). Defective IL-2 secretion or IL-2–induced signaling 
events are unlikely to be solely responsible for the nTreg cell 
dysfunction because CD4+Foxp3+ cells from IL-2 or CD25 
knockout mice are as suppressive in vitro as WT cells (33). 
Because Foxp3 is expressed normally in WKO CD4+CD25+ 
cells, our data do not support a direct role for either WASP 
or antigen receptor–mediated signaling events in regulat-
ing Foxp3 expression and suggest that the suppressive defects 
in WKO nTreg cells are downstream and/or independent 
of Foxp3.
IL-10 appears to be a key player in the regulation of 
 autoimmunity in the colon. IL-10–producing T cells (Tr1) can 
prevent colitis induction in the CD45RB transfer model 
(23). However, regulatory T cells isolated from IL-10–defi -
cient mice do not protect against colitis induced by WT 
CD45RBhi cells (22). Further, injection of an anti–IL-10–
neutralizing antibody together with WT CD4+CD45RBlo 
cells abrogates suppression (22). In this report, in vitro stimu-
lation of WKO T cells was associated with a marked defect in 
IL-10 secretion, suggesting a contributing role for IL-10 in 
WKO nTreg cell dysfunction in vivo (Fig. 7). However, pre-
liminary data suggest that IL-10 supplementation at the time 
of suppression does not rescue the defects in suppression 
 observed in vitro by WKO nTreg cells (unpublished data).
Abnormalities in nTreg cell function have been impli-
cated in the development of autoimmunity, immuno-
pathology, and allergy in several human diseases. The rare 
X-linked recessive autoimmune/infl ammatory syndrome IPEX 
(immune dysregulation, polyendocrinopathy, enteropathy, 
X-linked syndrome) is also associated with an autoimmune 
enteropathy (47). This disorder is caused by a mutation in 
Foxp3 and results from a profound reduction of CD4+CD25+ 
nTreg cells (48, 49). Our data now implicate regulatory T 
cell dysfunction in the pathogenesis of the immune dysregu-
lation associated with another human disorder, the auto-
immunity associated with the Wiskott-Aldrich syndrome (Fig. 
7). Lending further support to this hypothesis are recent data 
identifying defects in suppression in human nTreg cells anal-
ogous to those described herein with murine nTreg cells 
(Marangoni et al., in this issue).
MATERIALS AND METHODS
Mice. WKO mice (129 SvEv background) were generated as described pre-
viously (6) and backcrossed >10 generations onto the BALB/c background. 
C.B-17 SCID mice were purchased from Taconic. Mice were maintained in 
specifi c pathogen-free animal facilities at Massachusetts General Hospital. 
WKO mice on both the 129 SvEv and BALB/c background developed 
colitis in our facility. All experiments were conducted after approval and 
 according to regulations of the Subcommittee on Research Animal Care 
at Massachusetts General Hospital.
Antibodies and reagents. PE- and allophycocyanin-labeled coupled 
anti-CD25 antibodies; FITC-conjugated or peridinin chlorophyll pro-
tein anti-CD4; FITC-conjugated anti-CD103; PE-coupled anti–CTLA-4; 
PE-coupled streptavidin; and PE- and FITC-coupled anti-CD45RB 
 antibodies were purchased from BD Biosciences. Biotinylated anti-GITR 
antibodies were purchased from R&D Systems, and intranuclear Foxp3 
staining was performed using the FITC-coupled anti-Foxp3 intracellular 
staining kit (eBioscience).
Flow cytometry. Flow cytometric analyses were performed on a FACS-
Calibur fl ow cytometer (Becton Dickinson) using CELLQuest software 
(Becton Dickinson). More than 10,000 events were recorded through a 
lymphocyte gate. Analyses of CD4+CD25+ cells from the thymus and lymph 
Figure 7. Proposed model for nTreg cell dysfunction and colitis 
development in WKO mice. Decreased nTreg cell numbers in both the 
thymus and the periphery (lymph nodes) are observed in WKO mice and 
may result from IL-2 defi ciency and TCR activation defects. IL-2 defi -
ciency, aberrant nTreg cell homing, activation, and reduced IL-10 secretion 
lead to impaired suppression of colitogenic T cells and colitis.
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nodes were performed on both the BALB/c and the 129 SvEv background, 
and similar fi ndings were obtained.
Isolation of cell subsets. For the CD45RB transfer studies, mesenteric 
lymph nodes were carefully dissected from 10 WT or WKO BALB/c mice, 
and lymphocytes were isolated by gently mincing the lymph nodes through 
a cell strainer in RPMI 1640 supplemented with 10% FCS, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 2 mM l-glutamine (all from Invitro-
gen), and 50 μM β-mercaptoethanol (Sigma-Aldrich). CD4+ cells were 
then negatively selected using magnetic cell sorting according to the manu-
facturer’s recommendations (CD4+ isolation kit; Miltenyi Biotec). 
CD45RBhi and CD45RBlo T cells from the CD4+ population were 
isolated using a MoFlo cell sorter (DakoCytomation). CD4+CD25+ T cells 
were isolated from the spleen and positively selected using magnetic cell 
sorting (regulatory T cell isolation kit; Miltenyi Biotec).
For the in vitro suppression assay, spleens were dissected from WT or 
WKO BALB/c mice, and splenocytes were isolated by gently mincing the 
spleens through a cell strainer in FCS-supplemented RPMI. Cells were then 
spun down and resuspended in ACK lysis buff er to lyse erythrocytes before 
proceeding to cell separation. CD4+CD25+ T cells were positively selected 
using magnetic cell sorting as described above (purity typically ranged be-
tween 90 and 95%). CD4+CD25− cells were isolated using the fl ow-through 
from the previous step, followed by further purifi cation with a CD4+ isola-
tion kit (Miltenyi Biotec). Purity typically was 95%.
APCs were isolated by incubating total WT splenocytes with an anti-
Thy1.2 antibody (Cedarlane Laboratories), followed by treatment with rab-
bit complement (1:10 dilution, 107 cells/ml; Cedarlane Laboratories) for 1 h 
at 37°C. Dead cells were removed using a lympholyte-M gradient (Cedar-
lane Laboratories). The resulting T cell–depleted splenocytes were treated 
with 50 μg/ml mitomycin in PBS for 20 min at 37°C and washed thor-
oughly before in vitro usage.
For lamina propria cell isolation, colons from WT and WKO mice were 
washed with PBS and digested with 2 mg/ml dispase (Invitrogen) at 37°C 
for 1 h in complete media (RPMI 1640 media supplemented with 4% FCS, 
2 mM l-glutamine, 10 mM Hepes, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, and 250 ng/ml amphotericin) to remove the epithelial compartment 
including intraepithelial lymphocytes. Samples were then minced into 
small pieces and further digested with 1 mg/ml collagenase (Invitrogen) and 
1.5 mg/ml dispase (Invitrogen) for 1 h at 37°C. After washing, cells were 
passed through a glass wool column and further purifi ed via a 40/70% Per-
coll gradient method to remove epithelial and dead cells. Cells at the inter-
face were isolated and washed with PBS before fl ow cytometric staining.
Functional assessment of nTreg cells in vivo. CD45RBhi, CD45RBlo, 
or CD4+CD25+ T cells were isolated from WT or WKO BALB/c mice as 
described above. At day 0, C.B-17 SCID mice were injected intraperitone-
ally with 4 × 105 CD4+CD45RBhi T cells alone or in combination with 
2 × 105 CD45RBlo or 105 CD4+CD25+ T cells. Mice were clinically assessed 
every week for signs of colitis. The clinical score was defi ned as follows: 
Wasting: 0, no wasting; 1, 0.1–10% loss of initial total body weight; 2, >10% 
loss of initial total body weight; diarrhea: 0, none; 1, soft stool; 2, watery 
and/or bloody; hunching/bristled fur/skin lesions: 0, unchanged; 1, any 
positive sign; rectum prolapse: 0, absent; 1, present. 8–12 wk after transfer, 
mice were killed and colons were dissected, fi xed in 10% buff ered formalin, 
and embedded in paraffi  n for histological analysis.
Histology and histological grading. Hematoxylin and eosin staining was 
performed using standard techniques. Histological grading was based on 
mucosal thickening (0–3), lymphocyte infi ltration (0–3), and crypt abscess 
occurrence (0–1).
In vivo homing assays. Analysis of homing of WKO nTreg cells was per-
formed as described previously (50). Single cell suspensions of spleen, mes-
enteric lymph node and peripheral lymph node lymphocytes were prepared 
from WT and WKO mice. First, 107 cells (for CD4+CD25− cells) and 
106 cells (for nTreg cells) of each population was labeled for 20 min at 37°C 
with either CFSE or TRITC (both from Invitrogen) spun down on an FBS 
gradient and washed three times with cold RPMI 1640 containing 10% FCS 
(Life Technologies). Cells were then mixed and injected in the retroorbital 
plexus of anesthetized WT recipient mice. Remaining cells were analyzed to 
determine the exact cell input. After 12–15 h, spleen, peripheral lymph 
nodes, and mesenteric lymph nodes from recipient mice were analyzed by 
FACS after gating for viable lymphocytes by forward and light scatter char-
acteristics. The relative frequency of the two donor cell populations was 
determined for each individual organ, and a homing index was calculated as 
described previously (50). Identical results were obtained when WT and 
WKO cells were stained with the alternative labeling agent.
In vitro suppression assays. For in vitro anti-CD3ε–induced prolifera-
tion, 5 × 104 CD4+CD25− cells were cultured in 96-well round-bottom 
plates together with 105 mitomycin-treated T cell–depleted splenocytes and 
0.5 μg/ml anti-CD3ε (BD Biosciences). CD4+CD25+ cells from WT or 
WKO mice were added to the culture in various ratios as indicated in Fig. 4. 
Proliferation was measured by pulsing the cells for 12 h with 1 μCi 
[3H]thymidine after 60 h of stimulation. For the preactivation of nTreg 
cells with IL-2, splenic nTreg cells from WT or WKO mice were cul-
tured with 10 μg/ml of plate-bound anti-CD3ε and 25 μg/ml IL-2 (both 
from BD Biosciences) for 3 d and washed extensively before the in vitro 
suppression assays.
Cytokine analysis in culture supernatant. CD4+CD25− or CD4+CD25+ 
splenocytes from WT or WKO mice were isolated and cultured in the pres-
ence of 10 μg/ml of plate-bound anti-CD3ε and 25 μg/ml IL-2, or 5 ng/ml 
PMA and 500 ng/ml ionomycin (both from Sigma-Aldrich). After 3 d of 
stimulation, culture supernatants were harvested, spun down, and stored at 
−20°C before ELISA analysis. IL-10 concentrations were determined by 
ELISA as described previously (51).
T cell–bead conjugates. 10-μm latex beads were coated with 10 μg/ml 
anti-CD3ε and 10 μg/ml anti-CD28 (BD Biosciences) for 1 h at 37°C, 
washed thoroughly with PBS, and blocked with PBS/BSA 1% for 30 min. 
Purifi ed T cell subsets (2 × 105 cells/ml) were then incubated with the 
coated beads (4 × 105 beads/ml) for 10 or 30 min in supplemented medium 
(RPMI 1640) at 37°C to create T cell–bead conjugates. The conjugates were 
then plated on poly-l-lysine–coated coverslips for 10 min and fi xed with 4% 
paraformaldehyde. Cells were then permeabilized using 0.2% Triton X-100 
in PBS and actin stained with AlexaFluor-488 Phalloidin (Cambrex Bio 
Science Inc.). Coverslips were then mounted using Vectorshield mounting 
medium (Vector Laboratories) and examined by fl uorescence microscopy 
(100× objective). Cells were defi ned as polarized if the intensity of the actin 
staining was stronger on the pole of the cell in contact with the bead, whereas 
unpolarized cells were defi ned as having a uniform staining pattern.
T cell spreading. Coverslips were coated with 10 μg/ml anti-CD3ε and 
10 μg/ml anti-CD28 (BD Biosciences) for 1 h at 37°C and washed thor-
oughly. 105 CD4+CD25− or CD4+CD25+ cells from WT or WKO animals 
were then incubated on coated coverslips for the desired time and fi xed, 
permeabilized, stained, and mounted as described above. Spread cells were 
defi ned as cells having a fl attened lamellipodia-like sheath of actin, whereas 
unspread cells were round in shape.
Statistical analysis. Signifi cance was assessed for nTreg cell numbers us-
ing the Mann-Whitney test. For intergroup comparisons in the CD45RB 
transfers as well as in the actin polarization and spreading experiments, an 
unpaired two-tailed Student’s t test was used. p-values of <0.05 were 
 considered signifi cant.
Online supplemental material. Fig. S1 characterizes CD25 and Foxp3 
expression of WKO CD4+CD45RBlo cells. Table S1 gives the raw data of 
the three independent experiments (shown in Fig. 4) assessing spreading and 
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actin polarization of WT or WKO CD4+CD25− cells and nTreg cells. The 
online supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20061338/DC1.
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